Biophysical characterization of naturally occurring titin M10 mutations

• Published in: Protein science Vol. 24; no. 6; pp. 946 - 955
• Main Authors: Rudloff, Michael W., Woosley, Alec N., Wright, Nathan T.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.06.2015; BlackWell Publishing Ltd
• Subjects: Amino Acid Sequence; Connectin - chemistry; Connectin - genetics; Connectin - metabolism; Humans; LGMD2J; M10; Molecular Dynamics Simulation; Molecular Sequence Data; Muscular Dystrophies - genetics; Mutation - genetics; Mutation - physiology; NMR; Nuclear Magnetic Resonance, Biomolecular; obscurin; Protein Stability; Protein Structure, Tertiary; titin; titinopathy; TMD; titin; NMR; titinopathy; LGMD2J; obscurin; TMD; M10
• ISSN: 0961-8368; 1469-896X
• DOI: 10.1002/pro.2670

The giant proteins titin and obscurin are important for sarcomeric organization, stretch response, and sarcomerogenesis in myofibrils. The extreme C‐terminus of titin (the M10 domain) binds to the N‐terminus of obscurin (the Ig1 domain) in the M‐band. The high‐resolution structure of human M10 has been solved, along with M10 bound to one of its two known molecular targets, the Ig1 domain of obscurin‐like. Multiple M10 mutations are linked to limb‐girdle muscular dystrophy type 2J (LGMD2J) and tibial muscular dystrophy (TMD). The effect of the M10 mutations on protein structure and function has not been thoroughly characterized. We have engineered all four of the naturally occurring human M10 missense mutants and biophysically characterized them in vitro. Two of the four mutated constructs are severely misfolded, and cannot bind to the obscurin Ig1 domain. One mutation, H66P, is folded at room temperature but unfolds at 37°C, rendering it binding incompetent. The I57N mutation shows no significant structural, dynamic, or binding differences from the wild‐type domain. We suggest that this mutation is not directly responsible for muscle wasting disease, but is instead merely a silent mutation found in symptomatic patients. Understanding the biophysical basis of muscle wasting disease can help streamline potential future treatments.